Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Diflunisal
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Diflunisal 250mg tablets
1001010D0AAAAAA
|
Diflunisal | Diflunisal | Musculoskeletal and Joint Diseases | No data available |
|
Diflunisal 500mg tablets
1001010D0AAABAB
|
Diflunisal | Diflunisal | Musculoskeletal and Joint Diseases | No data available |
|
Dolobid 250mg tablets
1001010D0BBAAAA
|
Dolobid | Diflunisal | Musculoskeletal and Joint Diseases | No data available |
|
Dolobid 500mg tablets
1001010D0BBABAB
|
Dolobid | Diflunisal | Musculoskeletal and Joint Diseases | No data available |
|
Novo-Diflunisal 250mg tablets
1001010D0BCAAAA
|
Novo-Diflunisal | Diflunisal | Musculoskeletal and Joint Diseases | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.